170 filings
Page 6 of 9
6-K
VALN
Valneva SE
1 Mar 22
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
9:00am
6-K
VALN
Valneva SE
23 Feb 22
Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development
4:30pm
SC 13G
VALN
Valneva SE
10 Feb 22
Valneva SE / Bpifrance Participations ownership change
10:54am
6-K
VALN
Valneva SE
4 Feb 22
Valneva Reports Full Year 2021 Revenue and Cash; Provides First 2022 Guidance
9:00am
6-K
VALN
Valneva SE
1 Feb 22
Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate
4:30pm
6-K
VALN
Valneva SE
26 Jan 22
Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate
4:45pm
6-K
VALN
Valneva SE
19 Jan 22
Current report (foreign)
2:00pm
6-K
VALN
Valneva SE
10 Jan 22
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
9:00am
6-K
VALN
Valneva SE
23 Dec 21
Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate
1:00pm
6-K
VALN
Valneva SE
16 Dec 21
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
5:00pm
6-K
VALN
Valneva SE
9 Dec 21
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001
12:00pm
6-K
VALN
Valneva SE
3 Dec 21
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
5:00pm
6-K
VALN
Valneva SE
26 Nov 21
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
12:00pm
6-K
VALN
Valneva SE
18 Nov 21
Valneva to Present its Chikungunya Vaccine Candidate at the ASTMH 2021 Annual Meeting
1:00pm
6-K
VALN
Valneva SE
10 Nov 21
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference
11:00am
6-K
VALN
Valneva SE
3 Nov 21
Valneva Announces Closing of Approximately $102.0 Million Global Offering
5:00pm
6-K
VALN
Valneva SE
1 Nov 21
Current report (foreign)
5:00pm
424B4
VALN
Valneva SE
1 Nov 21
Prospectus supplement with pricing info
4:06pm
6-K
VALN
Valneva SE
29 Oct 21
Valneva Announces the Pricing of its Global Offering of American Depositary Shares and Ordinary Shares
4:30pm
EFFECT
VALN
Valneva SE
29 Oct 21
Notice of effectiveness
12:15am